Logo Cellply

Cellply is pleased to announce its participation in European Biotech Week 2024 hosting an open webinar exploring the unique assay flexibility of VivaCyte

Events

Cellply is pleased to announce its participation in European Biotech Week 2024 hosting an open webinar exploring the unique assay flexibility of VivaCyte

European Biotech Week 2024

Uncovering hidden immune cell killing to understand anti-tumor activity

How Biotech supports us in everyday life

Cellply will take part in the European Biotech Week, that will take place all over Europe, to celebrate biotechnology and its applications.

JOIN OUR WEBINAR!

September 26 at 2.00 – 3.00 p.m CEST

Novel approach to uncover hidden killing activity within a cell therapy population and reveal which subsets have the potential to exhibit a dominant role in anti-tumor activity.

Presenter: Francesco Imperatore, Field Application Scientist, Cellply

Cellply is pleased to announce its participation in European Biotech Week 2024 hosting an open webinar exploring unique assay flexibility of VivaCyte

Why should you join?

  • See how measuring multiple functional and phenotypic properties on the same immune cells, without pre-sorting, can identify hidden cells with unique killing characteristics.
  • Hear how the VivaCyte platform provides a unique combination of single-cell resolution, flexible assay design, and automation at scale, while using 10-fold less cells than traditional analysis techniques.
  • Learn about real-world examples of how these new data are providing insights for therapy developers not previously available, and influencing better candidate selection.
WHEN

September 26 at 2.00 - 3.00 p.m CEST

The goal of the European Biotech Week is to tell to a wide and diverse audience about biotechnologies in their various fields of application (from therapy to diagnostics, from agribusiness to industrial processes, through environmental remediation to renewable energy, to name a few). But also to celebrate the key role these technologies play in improving the quality of life for all of us.

continue reading

You may also like

News

Eurofins Biopharma Product Testing (BPT) Italy and Cellply announce strategic partnership to foster cell and gene therapy development through single-cell characterisation

29 August 2024
Webinar

Webinar: Rapid single cell functional characterization for cell therapy potency

12 July 2024
News

Cellply passed the phase 2 of Call4Innovit program and will go to San Francisco

23 May 2024
Events

Advancing TCR-based Cell Therapies & Bispecific Approaches

24 April 2024
Press release

Nature Biotechnology publishes research from DKFZ and Cellply highlighting novel approach for accelerating cellular immunotherapy development

19 March 2024
Events

Dual attendance for Cellply at March’s leading events in the cell therapy industry.

18 March 2024
Events

Launch of VivaCyte® at Advanced Therapies Week 2024

26 January 2024
News

Cellply launches its end-to-end single cell potency characterization platform VivaCyte

17 January 2024
Events

Cellply at Advanced Therapies Week 2024

4 January 2024
News

Cellply – Fesr programme 2021-2027

28 December 2023
Press release

Cellply concludes a new internal round of €3.6 million and extends the round to new investors!

27 September 2023
News

CellPly announces acceptance of one abstract at the CICON23 conference

18 September 2023
Press release

CellPly announces Emiliano Spagnolo as the new CEO

27 July 2023
News

L’innovazione Cellply in un articolo sulla rivista Le Scienze

4 March 2020
Events

Cellply to present new method for evaluating immunotherapy efficacy at the 61th ASH Annual Meeting

25 November 2019
News

Cellply wins the €300k Gaetano Marzotto prize and Unicredit StartLab prize

22 November 2018
Events

Cellply invited to present at the World Health Summit 2019

22 October 2018
News

Cellply selected as finalist at Lyfebulb Oncology Award

1 March 2018
Events

Cellply abstract accepted at the AACR 2018 Annual Meeting

4 February 2018
Press release

Cellply and Sant’Orsola-Malpighi Polyclinic to present one abstract on AML patient stratification with the Open Microwell platform at the 58th ASH Annual Meeting

4 November 2016
News

Cellply wins an H2020 SME Instrument Phase 1 grant

20 October 2016
Keep in touch

Need some infos?

Drop us a line or give us a ring. We love to hear from you and are happy to answer any questions.